Inventor · disambiguated record
Valsamo Anagnostou
Also filed as: ANAGNOSTOU VALSAMO
0 granted patents·10 pending applications·0 citations·filing 2010–2023
Top patents by PatentIndex Score
10 records- 0179US2024269179A1Neoantigens as targets for immunotherapyUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0259US2019247435A1Neoantigens as targets for immunotherapyUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 0357US2025003008A1Methods for treatment of cancerUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0454US2023002831A1Methods and compositions for analyses of cancerUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 0553US2022154295A1Methods and materials for assessing and treating cancerUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 0653US2021155986A1Non-invasive detection of response to immunotherapyUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 0745US2014170135A1Egfr expression is associated with decreased benefit from trastuzumab in the ncctg n9831 trialRIMM DAVID L·Filed 2013·Application pending·0 cites
- 0843US2014148353A1Protein expression-based classifier for prediction of recurrence in adenocarcinomaRIMM DAVID L·Filed 2012·Application pending·0 cites
- 0942US2019240257A1Compositions and methods for identifying functional anti-tumor t cell responsesUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1041US2012245051A1Objective, quantitative method to predict histological subtype in non-small cell lung cancerRIMM DAVID L·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valsamo Anagnostou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →